Multimorbidity in Asthma, Allergic Conditions and COPD Increase Disease Severity, Drug Use and Costs: The Finnish Pharmacy Survey

International Archives of Allergy and Immunology

Volumn 179, Issue 4, 2019, Pages 273-280

  Jantunen, Juha ^a   Haahtela, Tari ^b   Salimäki, Johanna ^c   Linna, Miika ^d   Mäkelä, Mika ^b   Pelkonen, Anna ^b   Kauppi, Paula ^b  

^a Etela karjalan Allergia ja Ymparistoinstituutti   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Association of Finnish Pharmacies   (Finland)

^d AALTO UNIVERSITY   (Finland)

Author keywords

Allergic rhinitis; Asthma costs; Asthma multimorbidity; Atopic eczema; Pharmacotherapy

Indexed keywords

ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; EYE DROPS; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NOSE SPRAY; OMALIZUMAB; THEOPHYLLINE;

ADULT; ALLERGIC CONJUNCTIVITIS; ALLERGIC DISEASE; ALLERGIC RHINITIS; ALLERGY PATIENT; ANAPHYLAXIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONJUNCTIVITIS; DISEASE SEVERITY; DRUG COST; DRUG USE; FEMALE; FOOD ALLERGY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE CHRONIC CONDITIONS; NOSE OBSTRUCTION; PRIORITY JOURNAL; SELF REPORT; ADOLESCENT; AGED; CHILD; COMORBIDITY; COST; DRUG UTILIZATION; ECONOMICS; FINLAND; HYPERSENSITIVITY; PHARMACY (SHOP); PRESCHOOL CHILD; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CHILD; CHILD, PRESCHOOL; COMORBIDITY; COSTS AND COST ANALYSIS; DRUG UTILIZATION; FINLAND; HUMANS; HYPERSENSITIVITY; MIDDLE AGED; PHARMACY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85064983658     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000498861     Document Type: Article

References (30)

1. Haahtela T, Valovirta E, Bousquet J, Mäkelä M; Allergy Programme Steering Group. The Finnish Allergy Programme 2008-2018 works. Eur Respir J. 2017 Jun; 49(6): 1700470.
2. Pallasaho P, Juusela M, Lindqvist A, Sovijärvi A, Lundbäck B, Rönmark E. Allergic rhinoconjunctivitis doubles the risk for incident asthma-results from a population study in Helsinki, Finland. Respir Med. 2011 Oct; 105(10): 1449-56.
3. Pinart M, Benet M, Annesi-Maesano I, von Berg A, Berdel D, Carlsen KC, et al. Comorbidity of eczema, rhinitis, and asthma in IgEsensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med. 2014 Feb; 2(2): 131-40.
4. Cingi C, Gevaert P, Mösges R, Rondon C, Hox V, Rudenko M, et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy. 2017 Jun; 7(1): 17.
5. Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013 Oct; 107(10): 1481-90.
6. Global initiative for asthma. Global strategy for asthma management and prevention, 2017. Available from: www.ginasthma.org
7. WHO Collaborating Center for Asthma and Rhinitis; Bousquet J, Anto JM, Demoly P, Schünemann HJ, Togias A, Akdis M, et al. Severe Chronic Allergic (and Related) Diseases: A uniform approach-A MeDALL-GA-2LEN-ARIA Position paper. Int Arch Allergy Immunol. 2012; 158(3): 216-31.
8. Gionfriddo MR, Hagan JB, Rank MA. Why and how to step down chronic asthma drugs. BMJ. 2017 Oct; 359:j4438.
9. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006 Aug; 61(8): 663-70
10. Kauppi P, Linna M, Martikainen J, Mäkelä MJ, Haahtela T. Follow-up of the Finnish Asthma Programme 2000-2010: reduction of hospital burden needs risk group rethinking. Thorax. 2013 Mar; 68(3): 292-3
11. Kauppi P, Peura S, Salimäki J, Järvenpää S, Linna M, Haahtela T. Reduced severity and improved control of self-reported asthma in Finland during 2001-2010. Asia Pac Allergy. 2015 Jan; 5(1): 32-9
12. Salo T, Peura S, Salimäki J, Maasilta P, Haahtela T, Kauppi P. Need for medication and stuffy nose predict the severity of allergic rhinitis. Asia Pac Allergy. 2016 Apr; 6(2): 133-5
13. Association of Finnish Pharmacies. Drug search. 2017 [cited 2017 Dec 8]. Available from: https://laakehaku.apteekkariliitto.fi/Hakutulokset.aspx
14. Kapiainen S, Väisänen A, Haula T. Terveyden-ja sosiaalihuollon yksikkökustannukset Suomessa vuonna 2011. [The unit costs of health and social care in Finland in 2011.] Reports 3/2014. Helsinki: National Institute for Health and Welfare; 2014
15. Jantunen J, Kauppi P, Linna M, Martikainen J, Mäkelä M, Pelkonen A, et al. Astman ja allergian kustannukset ovat suuret mutta laskussa [Asthma and allergy costs in Finland are high but decreasing]. Suomen Lääkärilehti. 2014; 9: 641-7
16. Kauppi P, Linna M, Jantunen J, Martikainen JE, Haahtela T, Pelkonen A, et al. Chronic comorbidities contribute to the burden and costs of persistent asthma. Mediators Inflamm. 2015; 2015: 819194
17. Clark VL, Gibson PG, Genn G, Hiles SA, Pavord ID, McDonald VM. Multidimensional assessment of severe asthma: A systematic review and meta-analysis. Respirology. 2017 Oct; 22(7): 1262-75
18. ten Brinke A, Grootendorst DC, Schmidt JT, De Bruïne FT, van Buchem MA, Sterk PJ, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol. 2002 Apr; 109(4): 621-6
19. Aguilar D, Pinart M, Koppelman GH, Saeys Y, Nawijn MC, Postma DS, et al. Computational analysis of multimorbidity between asthma, eczema and rhinitis. PLoS One. 2017 Jun; 12(6):e0179125
20. Ilmarinen P, Tuomisto LE, Niemelä O, Tommola M, Haanpää J, Kankaanranta H. Cluster Analysis on Longitudinal Data of Patients with Adult-Onset Asthma. J Allergy Clin Immunol Pract. 2017 Jul-Aug; 5(4): 967-978.e3
21. Ferreira MA, Vonk JM, Baurecht H, Marenholz I, Tian C, Hoffman JD, et al.; 23andMe Research Team; AAGC collaborators; BIOS consortium; LifeLines Cohort Study. Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nat Genet. 2017 Dec; 49(12): 1752-7
22. Anto JM, Bousquet J, Akdis M, Auffray C, Keil T, Momas I, et al. Mechanisms of the Development of Allergy (MeDALL): introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol. 2017 Feb; 139(2): 388-99
23. Siroux V, Ballardini N, Soler M, Lupinek C, Boudier A, Pin I, et al. The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults. Allergy. 2018 Jul; 73(7): 1447-58
24. Mandelin JM, Remitz A, Virtanen HM, Malmberg LP, Haahtela T, Reitamo S. A 10-year open follow-up of eczema and respiratory symptoms in patients with atopic dermatitis treated with topical tacrolimus for the first years. J Dermatolog Treat. 2010 May; 21(3): 167-70
25. McCracken JL, Veeranki SP, Ameredes BT, Calhoun WJ. Diagnosis and management of asthma in adults: a review. JAMA. 2017 Jul; 318(3): 279-90
26. Israel E, Reddel HK. Severe and Difficult-to-Treat Asthma in Adults. N Engl J Med. 2017 Sep; 377(10): 965-76
27. Haahtela T, Herse F, Karjalainen J, Klaukka T, Linna M, Leskelä RL, et al. The Finnish experience to save asthma costs by improving care in 1987-2013. J Allergy Clin Immunol. 2017 Feb; 139(2): 408-414.e2
28. Belhassen M, Demoly P, Bloch-Morot E, de Pouvourville G, Ginoux M, Chartier A, et al. Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control. Allergy. 2017 Jun; 72(6): 948-58
29. Colás C, Brosa M, Antón E, Montoro J, Navarro A, Dordal MT, et al.; Rhinoconjunctivitis Committee of the Spanish Society of Allergy and Clinical Immunology. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study. Allergy. 2017 Jun; 72(6): 959-66
30. Juusela M, Pallasaho P, Sarna S, Piirilä P, Lundbäck B, Sovijärvi A. Bronchial hyperresponsiveness in an adult population in Helsinki: decreased FEV1, the main determinant. Clin Respir J. 2013 Jan; 7(1): 34-44.